图书馆订阅: Guest
生物医学工程评论综述™

每年出版 6 

ISSN 打印: 0278-940X

ISSN 在线: 1943-619X

SJR: 0.262 SNIP: 0.372 CiteScore™:: 2.2 H-Index: 56

Indexed in

Human Umbilical Cord–Derived Stem Cells: Isolation, Characterization, Differentiation, and Application in Treating Diabetes

卷 46, 册 5, 2018, pp. 399-412
DOI: 10.1615/CritRevBiomedEng.2018027377
Get accessGet access

摘要

Stem cell therapy is one of the most promising and effective approaches for treating diabetes, due to stem cell nonimmunogenic and nonimmunosupressive properties. Mesenchymal stem cells (MSCs) derived from human umbilical cord have been widely used in cell-based therapies for clinical applications. Among their various properties, immunomodulatory and proregenerative capacities broaden their scope for treating diabetes. Owing to various problems that are involved in treating diabetes, our review focuses on modulating umbilical cord–derived MSCs (UCMSCs) without any genetic manipulation. Umbilical cord tissue contains a rich source of MSCs with intact stemness. UCMSCs have profound effects on the remodeling process, maintaining similar morphology to various organs and escalating vascularization. Because of their neonatal origin, MSCs have enormous immune properties that lead to greater therapeutic benefits, including enhanced insulin sensitivity in type 2 diabetic (T2D) animal models and treatment of complications such as diabetic ulcers and compromised wound healing. MSCs ameliorate hyperglycemia by reducing inflammation due to their anti-inflammatory nature. Furthermore, their differentiation potential enables use in T1D treatment, wherein MSCs alone or insulin-producing cells that are derived from these MSCs, when transplanted in streptozotocin, induce animals to experience reversal of hyperglycemia. In this review, we discuss methods of UCMSC isolation, characterization, differentiation potential, and various applications in diabetes treatment.

对本文的引用
  1. Li Fang, Zhang Kun, Liu Hua, Yang Tan, Xiao Dong-Jie, Wang Yun-Shan, The neuroprotective effect of mesenchymal stem cells is mediated through inhibition of apoptosis in hypoxic ischemic injury, World Journal of Pediatrics, 16, 2, 2020. Crossref

  2. Häfner Sophia Julia, Bargain with the tooth fairy – The savings accounts for dental stem cells, Biomedical Journal, 43, 2, 2020. Crossref

  3. He Qin, Wang Lingshu, Zhao Ruxing, Yan Fei, Sha Sha, Cui Chen, Song Jia, Hu Huiqing, Guo Xinghong, Yang Mengmeng, Cui Yixin, Sun Yujing, Sun Zheng, Liu Fuqiang, Dong Ming, Hou Xinguo, Chen Li, Mesenchymal stem cell-derived exosomes exert ameliorative effects in type 2 diabetes by improving hepatic glucose and lipid metabolism via enhancing autophagy, Stem Cell Research & Therapy, 11, 1, 2020. Crossref

  4. Li Lisha, Sima Yizhen, Wang Yan, Zhou Jing, Wang Ling, Chen Yisong, The cytotoxicity of advanced glycation end products was attenuated by UCMSCs in human vaginal wall fibroblasts by inhibition of an inflammatory response and activation of PI3K/AKT/PTEN, BioScience Trends, 14, 4, 2020. Crossref

  5. Bie Qingli, Zhai Ruixia, Chen Yanrong, Li Yingao, Xie Na, Wang Baoyi, Yuan Poyun, Zhou Xinjie, Cong Haiyan, Chang Xin, Xiong Huabao, Zhang Bin, Sox9 Is Crucial for Mesenchymal Stem Cells to Enhance Cutaneous Wound Healing, International Journal of Stem Cells, 14, 4, 2021. Crossref

  6. Bao Yu, Zhao Zhengyan, Gao Huihui, Effect of hTIMP‐1 overexpression in human umbilical cord mesenchymal stem cells on the repair of pancreatic islets in type‐1 diabetic mice, Cell Biology International, 45, 5, 2021. Crossref

  7. Ghoneim Mohamed A., Refaie Ayman F., Elbassiouny Batoul L., Gabr Mahmoud M., Zakaria Mahmoud M., From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Progress and Challenges, Stem Cell Reviews and Reports, 16, 6, 2020. Crossref

  8. Yang Shuo, Zhu Biao, Yin Peng, Zhao Lisheng, Wang Yizhu, Fu Zhiguang, Dang Ruijie, Xu Juan, Zhang Jianjun, Wen Ning, Integration of Human Umbilical Cord Mesenchymal Stem Cells-Derived Exosomes with Hydroxyapatite-Embedded Hyaluronic Acid-Alginate Hydrogel for Bone Regeneration, ACS Biomaterials Science & Engineering, 6, 3, 2020. Crossref

  9. Wei Zhiping, Yuan Jintao, Wang Gaoying, Ocansey Dickson Kofi Wiredu, Xu Zhiwei, Mao Fei, Fang Jian, Regulatory Effect of Mesenchymal Stem Cells on T Cell Phenotypes in Autoimmune Diseases, Stem Cells International, 2021, 2021. Crossref

  10. Liu Qiuli, Chen Xiaoyong, Liu Chang, Pan Lijie, Kang Xinmei, Li Yanli, Du Cong, Dong Shuai, Xiang Andy Peng, Xu Yan, Zhang Qi, Mesenchymal stem cells alleviate experimental immune-mediated liver injury via chitinase 3-like protein 1-mediated T cell suppression, Cell Death & Disease, 12, 3, 2021. Crossref

  11. Hu Jungen, Huang Yizhou, Tan Jie, Da Lincui, Xie Huiqi, Recellularization of Decellularized Whole Organ Scaffolds: Elements, Progresses, and Challenges, in Decellularized Materials, 2021. Crossref

  12. Feng Zheng, Yang Yalan, Liu Zhiguo, Zhao Weimin, Huang Lei, Wu Tianwen, Mu Yulian, Integrated analysis of DNA methylome and transcriptome reveals the differences in biological characteristics of porcine mesenchymal stem cells, BMC Genomic Data, 22, 1, 2021. Crossref

  13. Sun Yu-Liang, Shang Ling-Rui, Liu Rui-Hong, Li Xin-Yi, Zhang Sheng-Hui, Ren Ya-Kun, Fu Kang, Cheng Hong-Bin, Yahaya Badrul Hisham, Liu Yan-Li, Lin Jun-Tang, Therapeutic effects of menstrual blood-derived endometrial stem cells on mouse models of streptozotocin-induced type 1 diabetes, World Journal of Stem Cells, 14, 1, 2022. Crossref

  14. Kim Chris Gunwoo, Lee Jae Kyung, Cho Geum-Joon, Shin Ok Sarah, Gim Jeong-An, Small RNA sequencing of small extracellular vesicles secreted by umbilical cord mesenchymal stem cells following replicative senescence, Genes & Genomics, 2022. Crossref

  15. Hu Xinyuan, Liu Zhong, Zhou Xinru, Jin Qian, Xu Wenrong, Zhai Xiao, Fu Qiang, Qian Hui, Small extracellular vesicles derived from mesenchymal stem cell facilitate functional recovery in spinal cord injury by activating neural stem cells via the ERK1/2 pathway, Frontiers in Cellular Neuroscience, 16, 2022. Crossref

  16. Yang Fan, Ni Beibei, Liu Qiuli, He Fangping, Li Li, Zhong Xuemei, Zheng Xiaofan, Lu Jianxi, Chen Xiaoyan, Lin Huizhu, Xu Ruixuan, He Yizhan, Zhang Qi, Zou Xiaoguang, Chen Wenjie, Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota, Stem Cell Research & Therapy, 13, 1, 2022. Crossref

  17. Gu Yongwei, Du Yue, Jiang Liangdi, Tang Xiaomeng, Li Aixue, Zhao Yunan, Lang Yitian, Liu Xiaoyan, Liu Jiyong, αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma, Journal of Nanobiotechnology, 20, 1, 2022. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain